(7429.31052017.113000246) NOVIFRA_1 (Q2460624): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed an Item) |
||
Property / fund | |||
Property / fund: European Regional Development Fund / rank | |||
Normal rank |
Revision as of 00:13, 9 June 2020
Project in Italy financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | (7429.31052017.113000246) NOVIFRA_1 |
Project in Italy financed by DG Regio |
Statements
33,775.0 Euro
0 references
67,550.0 Euro
0 references
50.0 percent
0 references
25 September 2017
0 references
25 March 2019
0 references
2 October 2019
0 references
NEXT TECHNOLOGY TECNOTESSILE SOCIETA' NAZIONALE DI RICERCA R.L.
0 references
IL PROGETTO ?NOVIFRA? NASCE DALL?IDEA DI AIUTARE E CURARE LA COSIDDETTA ?UTENZA FRAGILE?, OVVERO PERSONE AFFETTE DA DEFICIT COGNITIVI O EMOZIONALI DI VARIO LIVELLO (DA ALZHEIMER NEI CASI PI? GRAVI E FREQUENTI), ATTRAVERSO DELLE TERAPIE CHE NON HANNO NEL FARMACO IL MEZZO PER GARANTIRE UNA VITA SERENA AI PAZIENTI, METTENDOLI MAGARI IN CONDIZIONE DI MANTENERE UN BUON GRADO DI AUTONOMIA SENZA DOVER SOPPORTARE EFFETTI COLLATERALI LEGATI ALL?ASSUNZIONE DI FARMACI. SOPRATTUTTO, L?IDEA CHE MUOVE LA REALIZZAZIONE DEI NUOVI SISTEMI ? PROPRIO L?INCREMENTO DELL?EFFICACIA DELLE TERAPIE NON FARMACOLOGICHE E QUINDI IL MIGLIORAMENTO DEL BENESSERE PERSONALE E DELLE CONDIZIONI DI VITA DEGLI UTENTI FRAGILI, SONO STATI PRESI A RIFERIMENTO SISTEMI SIMILARI SVILUPPATI IN AMBITI COMPLETAMENTE DIVERSI, OVVERO NEL MONDO INDUSTRIALE, DOVE SI MASSIMIZZA L?EFFICACIA DEI FLUSSI DI MATERIALI ATTRAVERSO LA LORO TRACCIABILIT? E L?ELABORAZIONE DELLA MOLE DI DATI RACCOLTI SUI FLUSSI STESSI.COME AFFERMA LO STUDIO REVISI (Italian)
0 references
THE PROJECT? NOVIFRA? DO YOU START FROM THE IDEA OF HELPING AND TREATING WHAT IS KNOWN AS A FRAGILE USER OR WITH COGNITIVE OR EMOTIONAL DEFICITS AT VARIOUS LEVELS (FROM ALZHEIMER’S IN IP CASES? WITH TREATMENTS THAT DO NOT HAVE THE MEANS OF ENSURING A LIFE SERENA TO PATIENTS, AND PERHAPS IN A POSITION TO MAINTAIN A GOOD DEGREE OF AUTONOMY WITHOUT HAVING TO BEAR SIDE EFFECTS LINKED TO THE RECRUITMENT OF MEDICINES, THROUGH TREATMENTS THAT DO NOT HAVE THE MEDICINE IN THE MEDICINE TO ENSURE A LIFE SERENA TO PATIENTS. ABOVE ALL, WHAT IS THE IDEA OF IMPLEMENTING THE NEW SYSTEMS? IS IT PRECISELY THE INCREASE IN THE EFFECTIVENESS OF NON-PHARMACEUTICAL THERAPIES AND THEREFORE THE IMPROVEMENT OF THE PERSONAL WELL-BEING AND LIVING CONDITIONS OF FRAGILE USERS, ARE SIMILAR SYSTEMS DEVELOPED IN COMPLETELY DIFFERENT AREAS, I.E. IN THE INDUSTRIAL WORLD, WHERE THE EFFECTIVENESS OF MATERIAL FLOWS THROUGH THEIR ACCIABILIT IS MAXIMISED? E L? DEVELOPMENT OF THE AMOUNT OF DATA COLLECTED ON THE STESSI.AS THE REVISI STUDY SAYS (English)
0 references
Identifiers
D55F17000910009
0 references